Last 12 months
Inside the activity.
1 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,281 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · derivative · entry 8 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,997 Underlying: Common Stock · 17,281 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 29, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 17,281 | $16.49 | $285,013.80 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.13 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 29, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 17,281 | $0.61 | $10,541.41 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,524 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · derivative · entry 11 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,278 Underlying: Common Stock · 13,524 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 13,524 | $16.91 | $228,636.74 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 8 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F6 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.50 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 13,524 | $0.61 | $8,249.64 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 7 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 541,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,028 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · derivative · entry 10 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 195,802 Underlying: Common Stock · 16,028 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 8,135 | $17.09 | $139,024.71 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F5 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.20. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 7,893 | $16.73 | $132,049.89 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 536,116 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.01. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 16,028 | $0.61 | $9,777.08 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 544,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,232 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · derivative · entry 9 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,830 Underlying: Common Stock · 17,232 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 6,370 | $17.24 | $109,793.32 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.69. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 10,862 | $16.49 | $179,131.76 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 534,351 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.005. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 00:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 17,232 | $0.61 | $10,511.52 |
DisclosureSEC source: 0001209191-23-040105 · doc4.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 23:30 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 6,481 | $17.51 | $113,463.52 |
DisclosureSEC source: 0001209191-23-039807 · doc4.xml · nonDerivative · entry 4 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,601,276 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F5 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.41 to $17.75. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 23:30 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 14,231 | $16.78 | $238,797.60 |
DisclosureSEC source: 0001209191-23-039807 · doc4.xml · nonDerivative · entry 3 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,607,757 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.335 to $17.195. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 23:30 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 500 | $17.39 | $8,693.00 |
DisclosureSEC source: 0001209191-23-039807 · doc4.xml · nonDerivative · entry 2 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,621,988 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.35 to $17.42. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 23:30 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 2,978 | $16.98 | $50,558.10 |
DisclosureSEC source: 0001209191-23-039807 · doc4.xml · nonDerivative · entry 1 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,622,488 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.29 to $17.29. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 1,100 | $18.18 | $19,998.99 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 7 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,625,466 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F8 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $18.11 to $18.395. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 14,027 | $17.71 | $248,357.85 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 6 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,626,566 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F7 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.075 to $18.035. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 4,629 | $16.12 | $74,614.85 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 5 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,640,593 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F6 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.00 to $16.905. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 1,300 | $16.53 | $21,493.29 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 4 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,645,222 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F5 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.04 to $16.82. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 16, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 600 | $18.50 | $11,100.00 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 3 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,646,522 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $18.00 to $19.00. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 16, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 50,838 | $17.06 | $867,296.28 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 2 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,647,122 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $17.00 to $17.98. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 16, 2023 Filed Jun 22, 2023 00:16 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 3,316 | $16.49 | $54,680.84 |
DisclosureSEC source: 0001209191-23-038945 · doc4.xml · nonDerivative · entry 1 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,697,960 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold within a one dollar price range. The actual sale prices range between $16.00 to $16.97. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 01:00 UTC |
Harris ToddDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,773 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001209191-23-037613 · doc4.xml · derivative · entry 6 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,837 Underlying: Common Stock · 12,773 shares Expires 2031-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 01:00 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 12,773 | $16.13 | $205,996.56 |
DisclosureSEC source: 0001209191-23-037613 · doc4.xml · nonDerivative · entry 4 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,701,276 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 01:00 UTC |
Harris ToddDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 12,773 | $2.25 | $28,739.25 |
DisclosureSEC source: 0001209191-23-037613 · doc4.xml · nonDerivative · entry 3 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,714,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,592 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · derivative · entry 9 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,062 Underlying: Common Stock · 12,592 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 12,592 | $16.15 | $203,301.62 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · nonDerivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.64. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 12,592 | $0.61 | $7,681.12 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · nonDerivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 540,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 120 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · derivative · entry 8 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 241,654 Underlying: Common Stock · 120 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 120 | $16.45 | $1,974.00 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 120 | $0.61 | $73.20 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 528,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 01:00 UTC |
Harris ToddDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,927 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001209191-23-037613 · doc4.xml · derivative · entry 5 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 389,610 Underlying: Common Stock · 7,927 shares Expires 2031-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 01:00 UTC |
Harris ToddDirector · Chief Executive Officer
|
SaleCommon Stock | 7,927 | $16.00 | $126,870.05 |
DisclosureSEC source: 0001209191-23-037613 · doc4.xml · nonDerivative · entry 2 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,701,276 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 01:00 UTC |
Harris ToddDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 7,927 | $2.25 | $17,835.75 |
DisclosureSEC source: 0001209191-23-037613 · doc4.xml · nonDerivative · entry 1 Harris Todd · CIK 0001711463 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,709,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,628 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · derivative · entry 7 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 241,774 Underlying: Common Stock · 5,628 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 5,628 | $16.01 | $90,129.04 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.38. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 00:58 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 5,628 | $0.61 | $3,433.08 |
DisclosureSEC source: 0001209191-23-037611 · doc4.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 533,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
Simson JakeDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033780 · doc4.xml · derivative · entry 1 Simson Jake · CIK 0001863094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), the RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund, the Nexus Fund, and the Account. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
KAPLAN GILLADirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033788 · doc4.xml · derivative · entry 1 KAPLAN GILLA · CIK 0001247024 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
CHEN ISANDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033769 · doc4.xml · derivative · entry 1 CHEN ISAN · CIK 0001586218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
Verjee RehanDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033786 · doc4.xml · derivative · entry 1 Verjee Rehan · CIK 0001880637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
Subramony SiddarthDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033779 · doc4.xml · derivative · entry 1 Subramony Siddarth · CIK 0001880624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. F2 · ownership.direct: These securities are owned directly by the Reporting Person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC, (iv) Joseph C. Lewis, and (v) the Reporting Person (collectively, the "Boxer Group"). Each member of the Boxer Group other than the Reporting Person disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund, L.P.Director · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001104659-23-067591 · tm2317680-1_4seq1.xml · derivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund, L.P. · CIK 0001780117 · Director · 10% owner Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. F1 · ownership.nature: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund") and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. F3 · ownership.nature: Under Mr. Simson's arrangement with the Adviser, Mr. Simson holds the option for the benefit of the Fund, the Nexus Fund, and the Account. Mr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund, the Nexus Fund, and the Account to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock except to the extent of their pecuniary interest. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
MORE ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033775 · doc4.xml · derivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
Kjellson Nina SDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0001209191-23-033774 · doc4.xml · derivative · entry 1 Kjellson Nina S · CIK 0001381980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2033-05-30 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 00:07 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-022432 · doc4.xml · derivative · entry 9 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,421 Underlying: Common Stock · 2,000 shares Expires 2031-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 00:07 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 2,000 | $16.16 | $32,313.80 |
DisclosureSEC source: 0001209191-23-022432 · doc4.xml · nonDerivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.